The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

INTRODUCTION: This study describes the results of the Belgian 'MabThera In Rheumatoid Arthritis (MIRA)' registry: effectiveness, safety and evaluation of the current retreatment practice on the background of the Belgian reimbursement criteria for rituximab. METHODS: All Belgian rheumatolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, Kaiser, Marie-Joelle, Hoffman, Ilse, De Keyser, Filip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990996/
https://www.ncbi.nlm.nih.gov/pubmed/20831776
http://dx.doi.org/10.1186/ar3129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990996/
https://www.ncbi.nlm.nih.gov/pubmed/20831776
http://dx.doi.org/10.1186/ar3129

Ejemplares similares